Clinical Trial Update: Evaluating Lapatinib + Capecitabine in Patients Aged 70 and Over With HER2 Metastatic Breast Cancer. [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the combination of lapatinib and capecitabine in patients aged 70 and older with HER2-positive metastatic breast cancer who prev…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Lapatinib (Lapatinib)

Snippet

Sponsor: UNICANCER | Conditions: Metastatic Breast Cancer, 70 Years Old Patients and Over | Phase 2 | Status: COMPLETED